STAGE IV CERVICAL CANCER AJCC V8
Clinical trials for STAGE IV CERVICAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV CERVICAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IV CERVICAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Custom-Made vaccine plus immunotherapy shows promise in advanced cancers
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own tumor proteins, given alone or with the immunotherapy drug pembrolizumab, for people with advanced solid tumors (like breast, lung, or skin cancer). The goal is to see if the combination is safe and helps the immun…
Matched conditions: STAGE IV CERVICAL CANCER AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 17, 2026 17:03 UTC
-
New hope for recurrent gynecologic cancers: Drug-Radiation combo enters human testing
Disease control Recruiting nowThis early-stage study tests a drug called talazoparib combined with radiation therapy for people whose gynecologic cancers (ovarian, endometrial, cervical, and others) have returned after prior treatment. The goal is to find the safest dose and see if the combination can shrink …
Matched conditions: STAGE IV CERVICAL CANCER AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
New registry aims to unlock secrets of rare cervical cancer
Knowledge-focused Recruiting nowThis study is creating a database of information from 750 people with a rare type of cervical cancer called neuroendocrine carcinoma. Researchers will look at medical records to understand how the disease behaves, what treatments patients receive, and what happens to them over ti…
Matched conditions: STAGE IV CERVICAL CANCER AJCC V8
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:56 UTC
-
New platform aims to predict which cancer treatments will work
Knowledge-focused Recruiting nowThis study collects tissue samples from people with various advanced or early-stage cancers to train a diagnostic platform called Elephas. The goal is to see how accurately it can predict whether a patient will respond to immunotherapy or chemoimmunotherapy. About 324 participant…
Matched conditions: STAGE IV CERVICAL CANCER AJCC V8
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:07 UTC